| 臺大學術典藏 |
2022-09-09T04:21:27Z |
Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:27Z |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
|
Liu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:26Z |
Response to “Iodized Oil CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Within Milan Criteria”
|
Wu C.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:26Z |
Highlights
|
JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:25Z |
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals
|
Chen Y.-C.; Chang T.-S.; Chen C.-H.; Cheng P.-N.; Lo C.-C.; Mo L.-R.; Chen C.-T.; Huang C.-F.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Dai C.-Y.; JIA-HORNG KAO; Chuang W.-L.; Lin H.-C.; Chen C.-Y.; Tseng K.-C.; Yu M.-L.; on behalf of TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:25Z |
Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study
|
Papatheodoridi M.; Su T.-H.; Hadziyannis E.; Liao C.-H.; Orfanidou Α.; Yang H.-C.; Zachou K.; Liu C.-J.; Kourikou A.; Gatselis N.; Manolakopoulos S.; Dalekos G.; JIA-HORNG KAO; Hadziyannis S.; Papatheodoridis G.V. |
| 臺大學術典藏 |
2022-09-09T04:21:25Z |
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis
|
You H.; Ma X.; Efe C.; Wang G.; Jeong S.-H.; Abe K.; Duan W.; Chen S.; Kong Y.; Zhang D.; Wei L.; Wang F.-S.; Lin H.-C.; Yang J.M.; Tanwandee T.; Gani R.A.; Payawal D.A.; Sharma B.C.; Hou J.; Yokosuka O.; Dokmeci A.K.; Crawford D.; JIA-HORNG KAO; Piratvisuth T.; Suh D.J.; Lesmana L.A.; Sollano J.; Lau G.; Sarin S.K.; Omata M.; Tanaka A.; Jia J. |
| 臺大學術典藏 |
2022-09-09T04:21:24Z |
Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine
|
Park J.; Le A.K.; Tseng T.-C.; Yeh M.-L.; Jun D.W.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung K.S.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H. |
| 臺大學術典藏 |
2022-09-09T04:21:24Z |
Letter to the editor: New kid in the playground: HBcrAg and risk of HCC
|
Wu J.-W.; Tseng T.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:23Z |
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
|
Lazarus J.V.; Mark H.E.; Villota-Rivas M.; Palayew A.; Carrieri P.; Colombo M.; Ekstedt M.; Esmat G.; George J.; Marchesini G.; Novak K.; Ocama P.; Ratziu V.; Razavi H.; Romero-G?mez M.; Silva M.; Spearman C.W.; Tacke F.; Tsochatzis E.A.; Yilmaz Y.; Younossi Z.M.; Wong V.W.-S.; Zelber-Sagi S.; Cortez-Pinto H.; Anstee Q.M.; Rouabhia S.; Ghazinyan H.; Iskandar N.J.; Trauner M.; Aghayeva G.; Carter F.; Sridharan K.; Al Mahtab M.; Francque S.; Kodjoh N.; Camacho R.M.; Anderson M.; Marques Souza de Oliveira C.P.; Mateva L.; Serme A.K.; Soares Martins A.A.; Swain M.G.; Komas N.P.; Zheng M.-H.; Jaramillo P.L.; Murillo O.A.; Mikolasevic I.; Vounou E.; Br?ha R.; Nlombi C.M.; Thiele M.; Perez M.; Su?rez M J.J.; Waked I.; Salupere R.; Desalegn H.; Yki-J?rvinen H.; Tsertsvadze T.; Sharvadze L.; Butsashvili M.; Awuku Y.A.; Papatheodoridis G.; Hunyady B.; Bjornsson E.S.; Duseja A.; Lesmana C.R.A.; Malekzadeh R.; Norris S.; Koike K.; Nersesov A.V.; Ochwoto M.; Jamal M.; Saparbu T.; Tolmane I.; Sayegh R.; Sheriff D.S.; Valantinas J.; Weber J.; Shawa I.T.; Tan S.-S.; Mart?nez V?zquez S.E.; Baatarkhuu O.; Lkhagvaa U.; Jadamba T.; Mohammed T.; Sudhamshu K.C.; Coppell K.; Onyekwere C.; Nikolova D.; Vesterhus M.; Al-Naamani K.; Hamid S.; M?ndez J.P.; Cabrera Cabrejos M.C.; Flisiak R.; Torres E.A.; Taheri S.; Sung K.-C.; Adela T.; Gheorghe L.; Sanai F.M.; Milovanovic T.; Bee Goh G.B.; Rac M.; Dassanayake A.; Osama S.B.; Elsanousi M.; Dufour J.-F.; JIA-HORNG KAO; Saidi D.; Treeprasertsuk S.; Koek G.; Labidi A.; Skrypnyk I.; AlKhatry M.S.; Sadirova S.; Bakieva S.; Sinkala E.; NAFLD policy review collaborators |
| 臺大學術典藏 |
2022-09-09T04:21:22Z |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang S.-C.; Cheng P.-N.; Liu C.-H.; Yang H.-C.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO; Liu C.-J. |
| 臺大學術典藏 |
2022-09-09T04:21:22Z |
Strategies for hepatitis C virus treatment failure
|
Huang S.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:22Z |
Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data
|
Lim Y.-S.; Seto W.-K.; Kurosaki M.; Fung S.; JIA-HORNG KAO; Hou J.; Gordon S.C.; Flaherty J.F.; Yee L.J.; Zhao Y.; Agarwal K.; Lampertico P. |
| 臺大學術典藏 |
2022-09-09T04:21:21Z |
Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients with Indeterminate Phase
|
Tseng T.-C.; Hosaka T.; Liu C.-J.; Suzuki F.; Hong C.-M.; Kumada H.; Yang W.-T.; Hsu C.-Y.; Su T.-H.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen H.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:21Z |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; Hsu S.-J.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L. |
| 臺大學術典藏 |
2022-09-09T04:21:20Z |
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities
|
Hsu Y.-C.; Tseng C.-H.; Su T.-H.; JIA-HORNG KAO; Nguyen M.H. |
| 臺大學術典藏 |
2022-09-09T04:21:20Z |
Sofosbuvir-based direct-acting antivirals for patients with decompensated hepatitis C virus-related cirrhosis
|
Liu C.-H.; Liu C.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:19Z |
Paradigm shift in the treatment options of hepatocellular carcinoma
|
Su T.-H.; Hsu S.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:18Z |
Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma
|
Wang S.-Y.; Su T.-H.; Chen B.-B.; Liu C.-J.; Liu C.-H.; Yang H.-C.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:18Z |
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan
|
Lo C.-C.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Chen C.-Y.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Liu C.-J.; Dai C.-Y.; Chuang W.-L.; Lin H.-C.; JIA-HORNG KAO; Yu M.-L.; TACR investigators |
| 臺大學術典藏 |
2022-09-09T04:21:16Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-06-14T23:24:05Z |
Sofosbuvir-based direct-acting antivirals for patients with decompensated hepatitis C virus-related cirrhosis
|
CHEN-HUA LIU; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-06-14T23:23:58Z |
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities
|
Hsu, Yao Chun; Tseng, Cheng Hao; TUNG-HUNG SU; JIA-HORNG KAO; Nguyen, Mindie H. |
| 臺大學術典藏 |
2022-04-14T23:27:17Z |
Long-term Evolution of Estimated Glomerular Filtration Rate in Patients With Antiviral Treatment for Hepatitis C Virus Infection
|
CHEN-HUA LIU; JOU-WEI LIN; CHUN-JEN LIU; TUNG-HUNG SU; Wu, Jo Hsuan; Tseng, Tai Chung; PEI-JER CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-03-14T23:45:22Z |
Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function
|
Li, Yung Tsung; CHUN-JEN LIU; JIA-HORNG KAO; Lin, Li Feng; Tu, Hui Chu; Wang, Chih Chiang; Huang, Po Hsi; Cheng, Huei Ru; PEI-JER CHEN; DING-SHINN CHEN; Wu, Hui Lin |
